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Background: Low back pain (LBP) is costly to society and improving patient outcomes is a priority. Stratifying LBP
patients into more homogenous groups is advocated to improve patient outcome. The STarT Back tool, a
prognostic screening tool has demonstrated efficacy and greater cost effectiveness in physiotherapy settings. The
management of LBP patients in groups is common but to date the utility of the STarT Back tool in group settings
has not been explored. The aim of this study is to determine if the implementation of ‘stratified care’ when
delivered in a group setting will lead to significantly better physical and psychological outcomes and greater cost
effectiveness in LBP patients compared to a bestcare historical control group.
Methods/Design: This study is a non randomised controlled trial. Low back pain patients recruited from the
Waterford Primary Care area (population = 47,000) will be stratified into low, medium or high risk of persisting
symptoms using the STarT Back Tool. Low risk patients will be offered a single one off education/exercise class
offering positive messages on LBP management in line with recommended guidelines. Medium risk patients will be
offered a 12 week group exercise/education intervention addressing their dominant physical obstacles to recovery.
A 12 week group cognitive behavioural approach will be delivered to the high risk patients, characterised by the
presence of high levels of psychosocial prognostic factors. These patients will be compared with a historical control
group where therapists were blinded as to the risk stratification of patients and a generic group intervention was
delivered to all patients, irrespective of their initial risk stratification. The primary outcome measure will be disability
(Roland Morris Disability Questionnaire). Secondary outcomes will include back pain intensity (Visual Analogue
Scale), distress (Distress and Risk Assessment Method), back beliefs (Back Beliefs Questionnaire), health status
(Euroqol), global benefit (7 point likert scale), satisfaction (7 point likert scale), cost effectiveness and functional
status. Outcome will be measured at baseline, 12 weeks and 6 months.
Discussion: This paper details the rationale, design, methods, planned analysis and operational aspects of a study
examining the utility of the STarT Back Tool as a ‘stratification tool for targeted treatment’ in a group intervention.
Trial registration: Current controlled trials: ACTRN12613000431729.
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Low back pain (LBP) is a major public health problem,
costly to society and can lead to disabling symptoms for a
large percentage of people. Symptoms are persistent, and
though many LBP patients cease consulting their General
Practitioner (GP) within a relatively short timeframe, 60-
80% of people still report pain and disability one year later
[1]. With regards to the management of LBP, guidelines
recommend that patients are initially offered conservative
management in the form of education and exercise/manual
therapy/acupuncture or a combination of a physical and
psychological treatment if individual interventions prove
ineffective [2]. Though the efficacy of these treatment in-
terventions has been established, in general outcomes from
studies are at best moderate [3,4], and improving patient
outcomes has become a priority amongst researchers.
Traditionally LBP has been broadly categorised into
three main groupings: non specific LBP (94%), nerve root
pain (5%) and red flag pathology (1%) [5]. The majority of
patients with LBP are classified as ‘non specific’ and a gen-
eric treatment pathway is administered to all, irrespective
of the underlying condition or psychosocial status. It has
been argued that this broad classification of LBP is too
heterogeneous and that patients with non specific LBP
should be sub-divided into more homogenous treatment
groups [6,7]. Sub-grouping and delivering targeted treat-
ment interventions has become a key focus for researchers
[8-10]. A number of classification systems have been pro-
posed including diagnostic, prognostic and treatment
based systems [11,12]. It has been well established that
psychosocial factors can lead to the persistence of LBP:
low mood, anxiety, catastrophisation and fear avoidance
[13,14]. Bearing this in mind, Hill et al. [15] developed a
prognostic screening tool the ‘STarT Back’ Tool which
stratifies patients on the presence of potentially modifiable
physical and psychological prognostic indicators for per-
sisting disabling low back symptoms. Patients are stratified
as low, medium or high risk of persisting symptoms and
treatment targeted accordingly. The STarT Back Tool was
developed in the primary care setting. It is simple to ad-
minister, patient friendly, and provides a welcome alterna-
tive to the more in-depth psychosocial questionnaires
which can be cumbersome in the primary care setting
[16]. The efficacy of the STarT Back screening tool has
been demonstrated in individual patient management in
the physiotherapy setting with both greater clinical and
cost effectiveness reported in the targeted subgroups com-
pared to usual care [10]. In view of its proven utility, the
STarT Back Tool is gaining more widespread use [17-19]
and its inclusion in spinal care pathways has been recom-
mended by the recently formed UK National Spinal Task-
force [20].
Within physiotherapy settings, different models of care
exist for the delivery of LBP interventions. The use ofgroup interventions incorporating rehabilitation and pro-
moting self management strategies are well established
[2,4]. The reported benefits of group intervention over in-
dividual treatment include greater throughput of patients,
treatment is more standardised which enhances outcome
measurement, a self management approach to treatment
is fostered and the delivery of group interventions has
proved more cost effective [21]. From a patient’s perspec-
tive, it proves enjoyable and allows patients to meet others
with a similar disposition [22,23]. To date, the STarT Back
tool has demonstrated efficacy when physiotherapy treat-
ment has been administered on an individual basis. This




The main objective of this study is to determine if the
implementation of ‘stratified care’ when delivered in a
group setting will lead to significantly better physical
and psychological outcomes in a group of patients with
non specific LBP, compared to a matched best care his-
torical control. The historical control group will consist
of individuals who attended the Back Pain Clinic be-
tween 2008 and 2011. Evaluation of treatment effect will
be made within each of the stratified treatment groups
and comparisons will be made between the stratified
group outcomes and best care historical control. Sec-
ondary analysis will compare the delivery costs of the
historical and stratified interventions.
Hypotheses
The following hypotheses will be tested.
1 Patient stratified to the ‘high risk’ intervention based
on the STarT Back tool will have better physical and
psychological outcomes compared with their
baseline scores and compared with the high risk
historical control group.
2 Patients stratified to the ‘medium’ and ‘low risk’
groups based on the STarT Back tool will have
significantly better physical and psychological
outcomes compared with their baseline scores and
equally good outcomes compared with the best-care
historical control.
Study design
This study is a non randomised controlled trial comparing
a new stratified intervention to a historical control treat-
ment, which is usual non-stratified care. The trial is thus
pragmatic in nature and aims to establish the effectiveness
of a treatment intervention in routine everyday practice
[24]. The study will determine if the implementation of
stratified care in a group setting, using the STarT Back
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physical and psychological outcomes in LBP patients,
compared with historical control data collected between
2009–2011 [25]. Patient assessments will occur at base-
line, at 12 weeks and 6 months following commencement
of the treatment intervention. The primary endpoint for
analysis is 6 months. Recruitment will take place between
February 2012 and June 2013.
This type of study design may be at risk of selection
bias, but the choice of historical controls was made to
allow comparability of interventions within a single clin-
ical centre, thus removing the risk of differences in man-
agement between centres. Furthermore, since the new
treatment paradigm necessitated a shift in management
approach to include cognitive behavioural principles with
subsequent staff training, the selection of historical con-
trols averted any possible loss of fidelity of the routine care
treatment which might have occurred if controls were re-
cruited concurrently to the new intervention group. Other
measures taken to minimise potential differences between
the intervention and control treatments include; the con-
trol and historical interventions will be delivered to the
same local population, referred from the same sources,
using standard diagnostic and referral criteria. Both the
historical and new interventions will be applied in the
same clinical setting by therapists who will apply the pre
and post treatment assessments in a standardised manner.
The same end points will be chosen for the stratified treat-
ment group as has been the practice for the historical con-
trols and there will be no time lag between the historical
data collection and the stratified intervention phase. This
can be considered an appropriate design in the current
study setting, where we have a large dataset documenting
existing routine evaluation of clinical treatment outcomes
[25]. Here the comparison of interest is between the exist-
ing standard management of LBP (the historical control
group), in a single centre, to a new paradigm of care
(intervention).
Patient recruitment, consent, allocation
Patients will be recruited from 10 GP practices and their
associated physiotherapy services within the Waterford
City Primary Care area. The Waterford City Primary
Care area serves a population of approx 47,000 people
[26]. Potential patients will be identified (based on the
inclusion criteria) when they consult their GP practice
or primary care physiotherapy team and subsequently
will be referred to the Back Pain Clinic at Waterford
Regional Hospital. On receipt of the referral, the Back
Pain clinic will forward an appointment to the patient,
in addition to a copy of the self report baseline question-
naires as per usual care and written information regard-
ing the study. On the initial screening day, the ‘STarT
Back’ screening tool will be administered and patientsstratified according to their level of risk of persisting
symptoms - low, medium or high risk. Patients will be
assessed as routine care. Routine care will include his-
tory taking, a physical examination, review of completed
self report questionnaires and performance of timed
functional outcome measures. Following the clinical as-
sessment, if patients are deemed suitable for the study, a
full explanation will be given by the principle investiga-
tor and any patient concerns addressed. If the patient is
then willing to participate, written consent will be ob-
tained (Figure 1).
The historical control consists of patients who attended
the Back Pain Clinic between 2009–2011. These patients
were referred from the 10 GP practices and their associ-
ated physiotherapy services within the Waterford City
Primary Care area in exactly the same manner as the
intervention group. The patients completed a copy of the
same self report questionnaires as the intervention group.
In the control group, risk stratification was performed by
an independent party (administrator at the clinic) after the
initial assessment using the STarT Back scoring algorithm.
The therapists were blinded as to the risk stratification of
each patient until completion of the treatment interven-
tion at three months. Patients in the historical control
group were assessed as routine care which included his-
tory taking, a physical examination, review of completed
self report questionnaires and performance of timed func-
tional outcome measures in exactly the same manner as
the intervention group. Following initial assessment if pa-
tients were deemed suitable, all patients irrespective of
their risk stratification were entered into a generic 12 week
group exercise/education intervention. Consent was ob-
tained retrospectively for the inclusion of these historical
controls in line with the National Consent Policy [27].
Eligibility criteria
Patients (male and female) with chronic non specific
LBP of more than three months duration and aged 18–
65 years will be included. Full details of inclusion/exclu-
sion criteria are summarised in Table 1.
Ethical approval
Ethical approval was obtained from Waterford Regional
Hospital Ethics committee Health Service Executive
(HSE) South in June 2011.
Screening tool
The STarT Back Prognostic screening Tool allows clini-
cians to stratify patients based on the presence of poten-
tially modifiable physical and psychological prognostic
indicators for persistent disabling symptoms [28]. Pa-
tients are stratified into one of three categories: ‘low risk’,
‘medium risk’ or ‘high risk’ of persisting symptoms. The
tool consists of 9 items and includes constructs on




Diagnosis Mechanical low back pain
Duration Greater than 3 months duration
Language English speaking and English literate
Consent Willing and able to give full consent
Exclusion
Pathology Suspected or confirmed serious spinal pathology
(cauda equine syndrome, fracture, metastatic,
inflammatory spinal disease, pre-existing
neurological condition)
Past medical history Illicit drug use, spinal surgery, spinal cord stimulator
implantation, cardiac history, psychiatric illness or
personality disorder, intellectual disorder
Pregnancy Suspected or confirmed pregnancy
Back Pain Clinic
Stratified care
Patient declines participation in 
study.
Patient allocated appointment 
as per usual care
but not included in study
Patients consult doctor with low back pain 
A referral is forwarded to the Back Pain Clinic
High Risk Group Medium Risk Group Low Risk Group
12 week group 
intervention including bio-
psychosocial model of 
pain, CBT and exercise 
component
12 week generic group 
intervention including 
positive messages on 
activity, benefits for 
exercise, ergonomic advice 
and a structured exercise 
programme.
A single 1.5 hr  
exercise/education 
intervention including 
positive messages on 
managing LBP
Patient attends usual care 
intervention. 
Outcome Evaluation at 12 WEEKS and 6 MONTHS Follow up at 12 WEEKS 
and 6 MONTHS
Self report questionnaires completed
Patient assessed by physiotherapist as routine care 
Patient stratification completed as per STarTBack Tool 
Written consent obtained if patient agreeable to participate.
Patient allocated to targeted treatment group
Back Pain Clinic
Non stratified care
HISTORICAL CONTROLS 2008-2011 
Self report questionnaires completed
Patient assessed by physiotherapist as routine care 
Patient stratification as per STarTBack Tool.
completed by clinic administrator
PHYSIOTHERAPISTS BLINDED AS TO RISK STRATIFICATION
12 week generic group intervention
including positive messages on activity, benefits 
for exercise, ergonomic advice and a structured 
exercise programme.
Outcome evaluation at 12 WEEKS
Low Risk Medium Risk High  Risk
Figure 1 Study flow chart.
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ersomeness, catastrophising, fear, anxiety and depres-
sion. Questions 5–9 encapsulate psychosocial features
associated with persistent LBP (psychosocial subscale).
The maximum score is 9. Patients are asked to agree or
disagree with statements numbered 1–8 and a score of 1
is allocated to each statement the patient agrees with.
The 9th item relates to bothersomeness and a score of 1
is allocated if the patient scores either ‘very much’ or
‘extremely’. Patients are classified as low risk of persist-
ing symptoms if they score 0–3 and high risk if scoring
4 or 5 on the psychosocial subscale. All intermediate pa-
tients are classified as medium risk. High risk patients
are characterised by the presence of high levels of psy-
chosocial prognostic factors, with or without the pres-
ence of physical factors whereas medium risk patients
are characterised by the presence of physical and some
psychosocial prognostic factors, but the physical features
are more dominant. Treatment intervention is directed
dependent on the baseline risk stratification [10]. The
tool has been validated against well established question-
naires regarding disability and psychological parameters
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lar to that of the longer Orebro Musculoskeletal Screen-
ing Questionnaire [15,29].
Treatment interventions
Following assessment patients will be streamed into one
of three treatment interventions based on the STarT
Back tool. All interventions will be grouped based and
delivered by physiotherapists employed in the Back
Screening Clinic.
Low risk intervention
Patients will attend a single 1.5 hour small group session
delivered by the physiotherapist promoting active man-
agement of their back symptoms and outlining positive
messages on maintaining a healthy spine in line with the
‘The Back Book’ [30]. This session will be conducted
within a biopsychosocial framework and it’s aim will be
to normalise the episode of LBP in line with the guide-
lines [2]. The benefits of exercise will be emphasised,
advice to increase activity levels will be given and infor-
mation on local exercise centres will be provided. Pa-
tients will be instructed with an exercise regime and
given a manual which contains information on LBP
management, the back exercises and a home exercise
log. Each group will consist of three to five patients. The
class will also offer the opportunity for patients to ask
questions regarding their LBP and self-management. Pa-
tients will be encouraged to become more active in their
lifestyles and to perform the back exercises on a regular
basis.
Medium risk intervention
Patients in this group present with predominantly phys-
ical prognostic indicators (disabling LBP, referred leg
pain and co-morbid pain) without high levels of psycho-
social distress. Patients will attend four 90-minute group
exercise/education sessions over four weeks. The con-
tent of the educational sessions will include positive
messages on managing LBP based on ‘The Back Book’
[30], discussion on the benefits of exercise, a review of
spinal anatomy, direction on lifting and handling, ergo-
nomic advice, weight management and the impact of
stress, anxiety and low mood on LBP. These sessions
will be conducted with a biopsychosocial framework.
Patients will be instructed with a stability exercise
programme. Each class is a progression from the previ-
ous one. All patients will receive a ‘programme’ manual
containing general educational information, instruction
in each exercise and a home exercise log. Patients will
be encouraged to perform the exercises independently at
home at least four times/week and to complete the exer-
cise log. Patients will also be encouraged to become
more active in their lifestyle and activities such aswalking, cycling, swimming or other forms of cardiovas-
cular exercises are encouraged and logged in the activity
diaries. Each group will consist of six to ten patients. Pa-
tients will maintain the exercise regime independently at
home for a further eight weeks following the classes and
will subsequently be reviewed at the clinic at 12 weeks.
Adherence to the progamme will be monitored by
reviewing the patients exercise log weekly and class
attendance.
High risk intervention
Patients in this group display high levels of psychosocial
distress around their LBP including elements of anxiety,
low mood or fear. Physiotherapists administering this
component of the intervention will receive extra training
in cognitive behavioural therapy (CBT). Patients will at-
tend four 120 min group sessions. The content of this
intervention is modelled on the ‘high risk’ intervention de-
livered in the original STarT Back Trial [10]. Sessions will
utilise cognitive behavioural strategies to address unhelp-
ful beliefs and behaviours around LBP. The CBT interven-
tion will include discussion of the bio-psychosocial model
of pain, the impact of persistent pain, goal setting based
around patient’s functional and social limitations, graded
activity, relaxation training, relapse management. It will
give the patient’s a better understanding of how they can
help themselves and will focus particularly on behaviour
change. It will teach the patients to identify and change
maladaptive behaviours and use cognitive techniques to
identify and challenge unhelpful and unrealistic thoughts
and beliefs. This will promote positive behaviour and
beliefs about physical activity and avoidance behaviour.
Specific psychological and practical skills to promote
self management of pain will be developed. Each session
will also include an exercise component similar to the
medium risk intervention and each patient will receive a
‘programme’ manual containing the relevant informa-
tion and exercises. Patients will be encouraged to per-
form the exercises independently at home at least four
times per week as well as adopting CBT principles e.g.
pacing and goal setting. Each group will consist of four
to six patients. Patients will continue the exercise re-
gime independently at home for 8 weeks following the
classes and will be reviewed at the clinic at 12 weeks.
Adherence to the programme will be monitored by
reviewing the patients exercise log weekly and class
attendance.
Best care historical control
The historical control consists of patients who at-
tended the clinic between 2009–2011 [25]. Patients were
stratified using the STarT Back screening tool but a
non-targeted (‘one treatment fits all’) model of care was
delivered to patients. All patients undertook the same
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promoting self management and rehabilitation. The effi-
cacy of this intervention has been established [25] and
subsequently this template was utilised to develop the
medium and high risk interventions. Similar to the
medium and high risk interventions, the historical control
comprised two phases. In phase one, patients attended
once weekly for four weeks and each class was 1.5 hours
in duration. Sessions included exercise and back edu-
cational information similar to the ‘medium risk’ inter-
vention already described. In phase two, patients
continued independently with the structured home ex-
ercise programme for a further eight weeks. Each group
consisted of six to ten patients. Validated self report and
objective physical outcome measures monitored pro-
gress at baseline and at 12 weeks. Outcomes utilised
included disability (Roland Morris Disability question-
naire (RMDQ)) [31], pain (Visual Analogue Scale (VAS))
[32], distress (Distress and Risk Assessment Method
(DRAM)) [33], back beliefs (Back Beliefs Questionnaire




A schematic view of the outcome measures and assessment
time lines is presented in Table 2.
Follow up assessment
Patients will be re-assessed at the clinic at week 12 for
follow up of primary and secondary outcome measures.
At 6 months, patients will be followed up by postal ques-
tionnaire. Maximising completion of follow-up question-
naires will be achieved by (1) texting the patient in
advance to inform them that the questionnaire is being




Primary Back pain disability Roland an
Secondary Pain Visual an
Distress Distress a
Beliefs Back Belie
Preference based health utility EQ-5D
Global perceived benefit Compare
Satisfaction scale Satisfactio
Objective spinal mobility Range of
Objective physical function Simmond
sit-stand,envelope, (3) following up with the patient by phone once
they have received the questionnaire.
Outcome measures
The outcome measures assess the domains of disability,
pain, psychosocial and health status, global perceived
benefit, satisfaction and functional status (Table 2). The
primary outcome measure will evaluate change in func-
tional disability due to LBP measured by the Roland
Morris Disability Questionnaire (RMDQ). The RMDQ is
widely used in LBP studies in Primary Care and has
demonstrated good validity, reliability and responsive-
ness [31]. All outcome measures demonstrate proven
validity and reliability in their particular domain - pain
(VAS 0–10) [32], anxiety and depression (DRAM) [33],
back beliefs (BBQ) [34], global perceived benefit scale
and satisfaction scale (seven point likert scale) [37].
Functional outcomes include sit to stand test, functional
reach test and 50 ft. walk test [35] and lumbar spine
flexion range of motion [36].
With respect to cost analysis, each patient will be
asked to complete a cost diary documenting their medi-
cation costs and health care costs (direct costs) for a
retrospective three months, prior to attending the clinic
and for the prospective six months while participating in
the study. The health economic evaluation will consist
of a cost benefit analysis and a cost utility analysis, with
utility measured by the EuroQol (EQ-5D) [38]. The cost
of each treatment strategy will be determined prospect-
ively and includes staff time, overheads and equipment.
Analyses
All data will be entered into the IBM Statistical Package
for the Social Sciences [39] and subsequently cleaned
and checked for normality. Baseline differences between
the treatment groups will be explored with independentmeasures Time-points
(months)
der, duration of LBP, employment status,
al attainment, medico-legal status
0
d Morris Disability Questionnaire 0,3,6
alogue scale 0,3,6
nd Risk Assessment Method 0,3,6
fs Questionnaire 0,3,6
0,3,6
d to symptoms at baseline (7 point likert scale) 0,3,6
n with care received (7 point likert scale) 0,3,6
motion T-12 & S1 0,3
’s Tests: 0,3
forward reach, 50-foot walk test
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pare pre to post intervention outcomes for each treatment
group to determine if a significant treatment effect is
achieved by each of the stratified interventions using
paired t-tests and Cohen’s d effect size statistics. The main
analysis will compare treatment response between the
stratified and control groups using analysis of covariance
(ANCOVA) models with baseline measures as the covari-
ate and treatment group as the between group factor. Stat-
istical significance will be set at p < 0.05. Missing data will
be imputed using the linear and logistic regression models
applied by the multiple imputation functions in SPSS and
an intention to treat analysis will be performed. We will
also conduct a complete case analysis for those cases
where we have complete follow up data. In the event of
non normal data, non parametric tests will be performed
instead. Exploratory economic analyses will be under-
taken. Costs of each intervention will be calculated and
quality-adjusted life years (QALYs) gained computed.
These will be compared between interventions using inde-
pendent t tests. Six month health care utilisation atten-
dances and associated costs will be calculated for each
patient and compared between the intervention groups
using chi square tests for categorical data and t tests for
continuous data.
Sample size and statistical power
The RMDQ has been chosen as the primary outcome
measure in keeping with prior research. Although a
change of 2.5 points on the RMDQ is considered to be a
minimum clinically important difference [40], prior re-
search has based sample calculations on a between group
difference of 1.8 points [4]. As the high risk intervention is
the new intervention, our first hypothesis will test the su-
periority of ‘stratified treatment’ over previous best care
for the high risk subgroup. Following statistical review of
both the original STarT Back trial [10] and existing data
held by the researcher (RMDQ Sdchange = 4.7; correlation
between pre and post RMDQ ρ = 0.592), sample size cal-
culation was performed to detect an effect size of 0.38 for
the new high risk intervention over controls, with 80%
power and alpha (two-tailed) = 0.05. After adjusting for
ANCOVA [41], the resulting minimum sample required
for each of the historical and new high risk groups is 72
patients (n = 144).
Equivalence of the stratified treatment model to stand-
ard care for medium and low risk groups will be deter-
mined if the lower boundary of the 95% CI around the
mean difference RMDQ does not exceed the 1.8 thresh-
old. For this one sided 2.5% non-inferiority hypothesis, a
minimum of 57 participants in each of the medium and
low risk historical and new treatment groups is neces-
sary (n = 228). Thus, the total minimum sample is 372
patients.Discussion
We have presented the rational and design of a study
exploring the delivery of a group intervention to LBP
patients where stratified care using the STarT Back psy-
chosocial screening tool was utilised and targeted treat-
ment implemented. Although it is generally accepted that
randomised controlled trials provide the highest level of
evidence, a non randomised controlled design was imple-
mented in this study as it mirrors real life clinical practice
and is the most cost neutral design for the limited re-
sources available [24]. There are naturally limitations to
non randomised controlled trials including the inability to
infer that the change in outcome is directly related to the
intervention. However as outlined earlier, every effort has
been made to standardise the delivery of care and thereby
minimise bias. The results of the study will be published
once the study is concluded.
Conclusions
This study will investigate the clinical and cost effective-
ness of a group intervention for LBP patients, where pa-
tients will be ‘stratified’ using the STarT Back prognostic
screening tool and a ‘targeted treatment’ approach will be
delivered. The study will recruit patients from the Water-
ford City primary Care Area and patients will be followed
up over a 6 month timeframe. Study recruitment com-
menced in February 2012 and is currently on target to
close in June 2013. Follow up is targeted for completion in
December 2013 and results will be finalised for publica-
tion by April 2014.
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